SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46: 76581
  • 2
    Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 58192
  • 3
    Ferley J, Shin HR, Bray F et al. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France. International Agency for Research on Cancer, 2010. Available at http://globocan.iarc.fr. Accessed July 2011
  • 4
    Bosetti C, Bertuccio P, Chatenoud L, Negri E, La VC, Levi F. Trends in mortality from urologic cancers in Europe, 1970–2008. Eur Urol 2011; 60: 115
  • 5
    Neppl-Huber C, Zappa M, Coebergh JW et al. Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths. Ann Oncol 2012; 23: 132534
  • 6
    Schroder FH, Hugosson J, Roobol MJ et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 2012; 366: 98190
  • 7
    Shao YH, Albertsen PC, Shih W, Roberts CB, Lu-Yao GL. The impact of PSA testing frequency on prostate cancer incidence and treatment in older men. Prostate Cancer Prostatic Dis 2011; 14: 3329
  • 8
    Larranaga N, Galceran J, Ardanaz E et al. Prostate cancer incidence trends in Spain before and during the prostate-specific antigen era: impact on mortality. Ann Oncol 2010; 21 (Suppl. 3): 839
  • 9
    Navarro C, Martos C, Ardanaz E et al. Population-based cancer registries in Spain and their role in cancer control. Ann Oncol 2010; 21 (Suppl. 3): 313
  • 10
    De AR, Francisci S, Baili P et al. The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis. Eur J Cancer 2009; 45: 90930
  • 11
    Boletín Oficial del Estado (BOE). General Health Law 14/1986, April 25. 101. 29-4-1986. BOE number 102, April 29, 1986
  • 12
    Spanish National Institute of Statistics. Estimated Population by Reference Date, Province, Gender and Age. Spanish National Institute of Statistics, Madrid; 2011
  • 13
    Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual, 7th edn. New York, USA: Springer, 2009
  • 14
    D'Amico AV, Whittington R, Malkowicz SB et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 96974
  • 15
    Doll R, Cook P. Summarizing indices for comparison of cancer incidence data. Int J Cancer 1967; 2: 26979
  • 16
    Sanchez MJ, Payer T, De AR, Larranaga N, Capocaccia R, Martinez C. Cancer incidence and mortality in Spain: estimates and projections for the period 1981–2012. Ann Oncol 2010; 21 (Suppl. 3): 306
  • 17
    Fournier G, Valeri A, Mangin P, Cussenot O. [Prostate cancer. Epidemiology. Risk factors. Pathology]. Ann Urol (Paris) 2004; 38: 187206
  • 18
    Platz EA, Giovannucci E. Prostate cancer. In Schottenfeld D, Fraumeni JF eds, Cancer Epidemiology and Prevention, 3rd edn. Oxford: Oxford University Press, 2006: 112850
  • 19
    Howlader N, Noone AM, Krapcho M et al. SEER Cancer Statistics Review, 1975–2008. Bethesda, MD: National Cancer Institute, 2011
  • 20
    Porten SP, Cooperberg MR, Konety BR, Carroll PR. The example of CaPSURE: lessons learned from a national disease registry. World J Urol 2011; 29: 26571
  • 21
    Cooperberg MR, Broering JM, Kantoff PW, Carroll PR. Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol 2007; 178: S1419
  • 22
    Shahinian VB, Kuo YF, Gilbert SM. Reimbursement policy and androgen-deprivation therapy for prostate cancer. N Engl J Med 2010; 363: 182232
  • 23
    Heidenreich A, Bellmunt J, Bolla M et al. EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease. Actas Urol Esp 2011; 35: 50114
  • 24
    Alcaraz A, Burgos FJ, Cozar JM et al. Prostate cancer in Spain: from guidelines to clinical practice. BJU Int 2011; 108: 616